Facility

How Is Novartis Transforming Radiopharma Production in the U.S.?
Management & Regulatory How Is Novartis Transforming Radiopharma Production in the U.S.?

Enhancing Manufacturing Capabilities Novartis is making significant strides in its efforts to expand manufacturing capabilities to meet the growing demand for radiopharmaceutical therapies aimed at treating cancer. To achieve this, the company is not only expanding an existing facility in

How Is DHL Boosting Boehringer’s Supply Chain Sustainability Goals?
Management & Regulatory How Is DHL Boosting Boehringer’s Supply Chain Sustainability Goals?

In a move that promises to set new standards in supply chain sustainability, DHL Supply Chain has joined forces with biopharmaceutical company Boehringer Ingelheim to transform its warehousing and logistics operations in Australia and New Zealand. The partnership aims to enhance efficiency,

How Will AstraZeneca’s $135M Sweden Plant Expansion Impact Biologics?
Management & Regulatory How Will AstraZeneca’s $135M Sweden Plant Expansion Impact Biologics?

AstraZeneca has set the wheels in motion to significantly expand its biomanufacturing capacities with a $135 million investment in the Sweden Biomanufacturing Center in Södertälje. This venture marks the company's largest single investment in the facility since its inception in 2021, indicating a

Fujifilm Diosynth Opens Expanded Biotech Facility in the UK
Management & Regulatory Fujifilm Diosynth Opens Expanded Biotech Facility in the UK

Fujifilm Diosynth Biotechnologies has taken a significant step toward bolstering its microbial production capabilities with the inauguration of a new microbial fermentation manufacturing facility in Billingham, UK. As a leading contract development and manufacturing organization (CDMO), the company

Tanvex Achieves FDA Approval for NYPOZI and Progresses TX-05 BLA
Management & Regulatory Tanvex Achieves FDA Approval for NYPOZI and Progresses TX-05 BLA

Tanvex BioPharma USA, Inc., a frontrunner in biologics development, has made significant strides by securing FDA approval for NYPOZI (filgrastim-txid) and advancing its Biologics License Application (BLA) for TX-05. These milestones underscore the company’s unwavering commitment to delivering

Novo Nordisk Expands Danish Plant to Meet Surging Drug Demand
Management & Regulatory Novo Nordisk Expands Danish Plant to Meet Surging Drug Demand

Novo Nordisk has announced a significant expansion of its manufacturing capabilities at its Køge site in Denmark, aiming to address the soaring global demand for its diabetes and obesity treatments. As one of the leading pharmaceutical companies worldwide, this move underlines Novo Nordisk's

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later